Executive record
Francis Knuettel II
Public governance roles and source-backed Claims for this individual.
More
Alpha ID: alpha:person:frederick-c-peters-iiVersion: public-0As of: 2026-10-03
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
CEO and CFO of Chromocell Therapeutics Corporation since 2023; manages Camden Capital LLC providing board services and fractional executive services. Extensive experience as CFO at multiple public companies including MJardin, Marathon Patent Group, and Aqua Metals; holds MBA in Finance from Wharton.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Claims
Executive career
- 2026 to end not publishedExecutive title: Vice President, Chief Financial Officer and Treasurer · Organization not publishedTG 10-K executive officers
- 2025 to end not publishedExecutive title: Director · Organization not publishedACQC 10-K executive officers
- Dates not publishedExecutive title: Chairman and CEO · Organization not publishedPAYC DEF 14A director slate
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
TG 10-K executive officers
sec filing · Source published: Mar 11, 2026 · Retrieved: May 5, 2026
Supports 2 claims
- Executive company: Executive at TREDEGAR CORP · Claim reviewed: May 5, 2026
- Executive title: Executive title: Vice President, Chief Financial Officer and Treasurer · Claim reviewed: May 5, 2026
ACQC 10-K executive officers
sec filing · Source published: Apr 15, 2025 · Retrieved: May 15, 2026
Supports 6 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Executive company: Executive at Relativity Acquisition Corp · Claim reviewed: May 15, 2026
- Executive title: Executive title: Director · Claim reviewed: May 15, 2026
- Other Company Role: Francis Knuettel II is also linked to Chromocell Therapeutics Corporation as Chief Executive Officer and Chief Financial Officer. · Claim reviewed: May 15, 2026
- Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026
PAYC DEF 14A director slate
sec filing · Source published: Apr 3, 2025 · Retrieved: May 14, 2026
Supports 7 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Board role: Board role: Lead Independent Director · Claim reviewed: May 14, 2026
- Committee assignments: Committee assignments: Audit, Compensation, Nominating/Governance · Claim reviewed: May 14, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Executive company: Executive at Community Financial Institutions Fund · Claim reviewed: May 14, 2026
- Executive title: Executive title: Chairman and CEO · Claim reviewed: May 14, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 14, 2026
Paycom Software, Inc. director board source
sec filing · Source published: Apr 3, 2025 · Retrieved: May 3, 2026
Supports 3 claims
- Board independence: Independent director · Claim reviewed: May 3, 2026
- Board membership: Serves on the board of Paycom Software, Inc. · Claim reviewed: May 3, 2026
- Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Biography
- published
- Board service
- published
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- published
- Background screening
- out of scope